CD8A and neoplasm: Based on these results, we used a tumor‐ and CD8+T‐cell co‐culture system to show that PTBP3 knockdown in tumor cells enhanced the anti‐tumor effects of CD8+T cells (Figure 3D; Figure S3A, Supporting Information).